Amer Beitinjaneh Selected Research

B-Cell Lymphoma (Lymphoma, B Cell)

1/2020

Incidence and risk factors associated with a syndrome of persistent cytopenias after CAR-T cell therapy (PCTT).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amer Beitinjaneh Research Topics

Disease

13	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2023 - 02/2016
12	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 01/2016
9	Neoplasms (Cancer) 11/2023 - 09/2013
8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2023 - 06/2017
7	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 01/2017
5	Infections 12/2023 - 01/2019
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2023 - 01/2018
4	Leukemia 01/2023 - 01/2018
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2023 - 01/2020
3	Bronchiolitis Obliterans Syndrome 01/2022 - 01/2019
2	T-Cell Lymphoma (Lymphoma, T Cell) 02/2024 - 05/2015
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2023 - 01/2020
2	Multiple Myeloma 10/2023 - 01/2022
2	Critical Illness (Critically Ill) 08/2023 - 01/2022
2	Primary Myelofibrosis (Myelosclerosis) 07/2023 - 01/2023
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023 - 05/2017
2	Cytokine Release Syndrome 01/2022 - 01/2020
2	Viremia 01/2022 - 01/2018
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2018
2	Lymphoma (Lymphomas) 07/2021 - 02/2016
2	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 01/2018
2	Cytopenia 01/2020 - 01/2018
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 01/2018
1	Rare Diseases (Rare Disease) 01/2024
1	Renal Insufficiency (Renal Failure) 08/2023
1	Mycoses (Diseases, Fungus) 01/2023
1	Residual Neoplasm 01/2023
1	cell-associated neurotoxicity 01/2022
1	Hemorrhage 01/2022
1	Herpesviridae Infections (Herpesvirus Infection) 01/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022
1	Cryptogenic Organizing Pneumonia 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Cytomegalovirus Infections (Inclusion Disease) 10/2021
1	COVID-19 08/2021
1	Febrile Neutropenia 01/2021
1	Dysbiosis 01/2021
1	Blast Crisis (Blast Phase) 10/2020
1	Bone Marrow Failure Disorders 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Brain Edema (Cerebral Edema) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Disease Progression 01/2020
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2019
1	Seizures (Absence Seizure) 01/2019

Drug/Important Bio-Agent (IBA)

8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 02/2016
6	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2020
4	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2022 - 02/2016
3	fludarabineIBA 07/2023 - 03/2011
3	Busulfan (Busulfex)FDA Link 07/2023 - 01/2019
2	Melphalan (Alkeran)FDA LinkGeneric 07/2023 - 11/2021
2	brexucabtagene autoleucelIBA 01/2023 - 01/2020
2	axicabtagene ciloleucelIBA 01/2022 - 01/2020
2	Calcineurin InhibitorsIBA 01/2022 - 02/2016
2	fms-Like Tyrosine Kinase 3IBA 01/2016 - 07/2010
1	Peptides (Polypeptides)IBA 01/2023
1	LigandsIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	serum P-component (CIt)IBA 11/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	Lenalidomide (CC 5013)FDA Link 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022
1	PlatinumIBA 01/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2021
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 07/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Penicillins (Penicillin)FDA Link 01/2021
1	tisagenlecleucelIBA 01/2020
1	Filgrastim (Neupogen)FDA Link 01/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	CytokinesIBA 01/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	2-aminoethylmethyl sulfoneIBA 01/2019
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	AntigensIBA 01/2018

Therapy/Procedure

34	Cell Transplantation 02/2024 - 03/2011
18	Transplantation 11/2023 - 02/2016
14	Therapeutics 01/2024 - 01/2018
5	Drug Therapy (Chemotherapy) 11/2023 - 01/2020
4	Hematopoietic Stem Cell Transplantation 10/2023 - 01/2018
4	Stem Cell Transplantation 01/2023 - 05/2015
4	Homologous Transplantation 11/2021 - 01/2016
2	Critical Care (Surgical Intensive Care) 12/2023 - 08/2023
2	Donor Selection 01/2023 - 03/2022
2	Haploidentical Transplantation 01/2022 - 01/2020
2	Activities of Daily Living (ADL) 01/2019 - 01/2019
1	Artificial Respiration (Mechanical Ventilation) 01/2023
1	Resuscitation 01/2020
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2019